Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-34,800
Closed -$15.1M 32
2022
Q1
$15.1M Sell
34,800
-8,700
-20% -$3.64M 2.84% 10
2021
Q4
$20.2M Buy
43,500
+35,500
+444% +$15.7M 3.43% 7
2021
Q3
$3.11M Buy
+8,000
New +$3.4M 0.27% 37

Other funds holding HUM

Inherent Group's HUM Position: Q2 2022 in Review

Inherent Group sold out of Humana (HUM) in Q2 2022, closing a stake of 34,800 shares — an estimated $15.1M sold.

Inherent Group first reported a position in HUM in Q3 2021 and held it in 3 quarters. The position peaked at $20.2M in Q4 2021. 959 funds tracked by Wall St. Rank hold HUM as of Q2 2022.

  • Inherent Group reported no remaining Humana position as of Q2 2022 after selling out during the quarter.
  • Inherent Group sold 34,800 Humana shares in Q2 2022, an estimated $15.1M.
  • Inherent Group first reported a position in Humana in Q3 2021 and held it in 3 quarters.
  • Inherent Group's Humana position peaked at $20.2M in Q4 2021.
  • 959 funds tracked by Wall St. Rank held Humana as of Q2 2022.

Based on Inherent Group's 13F filing for Q2 2022, filed 15 Aug 2022.